The USP7 inhibitor FT671 and the USP10/13 inhibitor Spautin-1 reduced concentration-dependently AD-TAU-induced seeded Tau aggregation with IC50 values of 410 and 590 nM, respectively (Figure 4B). This evidence concerns the gene MAPT and Alzheimer disease.